Riskpilot← Back to searchSign inGet full accessACADIA PHARMACEUTICALS A/S
A/SActiveCVR 19670694Hesteskoen 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 1996— employees
Revenue 2024
—
EBITDA margin
—
+34% vs 2023
Equity ratio
-2002.0%
Financial strength
Net profit 2024
DKK -99K
+34% vs 2023
| Revenue | — | — |
| EBITDA | DKK -99K | +34% |
| Net profit | DKK -99K | +34% |
| Total assets | DKK 55K | +1459% |
| Equity | DKK -1,1M | -10% |
| Employees | — | — |
Legal name
ACADIA PHARMACEUTICALS A/S
CVR number
19670694
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. november 1996
Share capital
DKK 601.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse, af to medlemmer af bestyrelsen i forening eller af et bestyrelsensmedlem i forening med en direktør.
Company purpose
Selskabets formål er at drive fabrikation af, handel med og forskning i medicinske, farmaceutiske, kemiske og tekniske produkter, processer og anlæg, samt anden i forbindelse hermed stående virksomhed efter bestyrelsens nærmere bestemmelse.
Address
Hesteskoen 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | -21 | -254 | -151 | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -258 | -57 | -147 | -56 | -45 | -74 | -47 | -75 | -57 | -21 | -254 | -151 | -99 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -258 | -57 | -147 | -56 | -45 | -74 | -47 | -75 | -57 | -21 | -254 | -151 | -99 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Profit before tax | -258 | -57 | -147 | -56 | -45 | -74 | -47 | -75 | -57 | -21 | -254 | -151 | -99 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -258 | -57 | -147 | -56 | -45 | -74 | -47 | -75 | -57 | -21 | -254 | -151 | -99 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 | 5 | 9 | 5 | 4 | 7 | 6 | 3 | 11 | 6 | 5 | 3 | 55 |
| Equity | -10 | -67 | -214 | -270 | -315 | -388 | -435 | -510 | -567 | -588 | -841 | -993 | -1.092 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 14 | 72 | 222 | 275 | 319 | 395 | 441 | 512 | 578 | 594 | 846 | 996 | 1.147 |
| Total debt | 14 | 72 | 222 | 275 | 319 | 395 | 441 | 512 | 578 | 594 | 846 | 996 | 1.147 |
EBITDA margin
-9936500.0%
This company
15.8%
Market median
-62889341% vs market
20122024
Equity ratio
-2002.0%
This company
38.2%
Market median
-5341% vs market
20122024
Return on equity
-9936500.0%
This company
18.4%
Market median
-54002817% vs market
20122024
Net profit margin
-9936500.0%
This company
8.1%
Market median
-122672940% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AL Management | Management | 1998 | — | — |
VC Management | Management | 1996 | — | — |
PH Management | Management | 1997 | — | — |
UA Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
AK Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
TY Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
UA Management | Management | 1999 | — | — |
NJ Audit | Audit | 1996 | — | — |
GF Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
JJ Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
BT Chief Executive Officer | Chief Executive Officer | 2001 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 1996 | — | — | |
| Board of Directors | 2003 | — | — | |
| Chairman | 2010 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 1996 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 1998 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 1997 | — | — | |
| Chairman | 1997 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 1997 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ACADIA PHARMACEUTICALS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anni Lotte Kirstine Pedersen | Management | 0 companies |
| Victor Christoffersen | Management | 0 companies |
| Peter Høngård Andersen | Management | 0 companies |
| Uli Alf Hacksell | Chief Executive Officer | 0 companies |
| Austin Kim | Chief Executive Officer | 0 companies |
| Todd Young | Chief Executive Officer | 0 companies |
| Uli Alf Hacksell | Management | 0 companies |
| Nis Jørn Bennetzen | Audit | 0 companies |
| Glenn Frederick Baity | Chief Executive Officer | 0 companies |
| Jennifer Jane Rhodes | Chief Executive Officer | 0 companies |
| Bo-Ragnar Tolf | Chief Executive Officer | 0 companies |
| Thomas Aasen | Board of Directors | 0 companies |
| Peter Francis Chae | Board of Directors | 0 companies |
| Sebastian Benjamin Bahn Christoffersen | Board of Directors | 0 companies |
| Martinus Adrianus van Osch | Board of Directors | 0 companies |
| Torsten Erik Rasmussen | Chairman | 0 companies |
| Martin Choy | Chairman | 0 companies |
| Helen Mimi Janniche | Board of Directors | 0 companies |
| Elena Heather Ridloff | Board of Directors | 0 companies |
| James Kenji Kihara | Board of Directors | 0 companies |
| Justin Thacker | Chairman | 0 companies |
| Povl Krogsgaard-Larsen | Board of Directors | 0 companies |
| Eric Miller | Chairman | 0 companies |
| Arne Gillin | Board of Directors | 0 companies |
| Mark Robert Brann | Chairman | 0 companies |